Teladoc Health
TDOC
761 hedge funds and large institutions have $17B invested in Teladoc Health in 2021 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 310 increasing their positions, 238 reducing their positions, and 117 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 310 | Existing positions reduced: 238
1.12% more ownership
Funds ownership: 82.8% → 83.93% (+1.1%)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
8% less funds holding
Funds holding: 829 → 761 (-68)
20% less capital invested
Capital invested by funds: $21.3B → $17B (-$4.35B)
38% less call options, than puts
Call options by funds: $1.67B | Put options by funds: $2.69B
50% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 117
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAMA
Nikko Asset Management Americas
New York
|
+$250M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$247M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$214M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103M |
| 5 |
Citigroup
New York
|
+$68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
-$391M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$98.7M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$83.3M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$43.7M |
| 5 |
Goldman Sachs
New York
|
-$39.6M |
TDOC Hedge Fund Activity: Q3 2021 in Review
761 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2021, worth a combined $17B — down 20% from $21.3B a quarter earlier.
Sellers outnumbered buyers: 117 funds closed out of TDOC and 59 opened new positions — a net loss of 58 holders — while 238 trimmed existing stakes and 310 added.
The largest buyer was Nikko Asset Management Americas, adding an estimated $250M. The largest seller was General Catalyst Group Management, cutting an estimated $391M.
- 761 institutional investors held Teladoc Health (TDOC) as of Q3 2021, down from 829 in Q2 2021.
- Funds reported $17B of Teladoc Health stock for Q3 2021, down 20% quarter-over-quarter.
- 59 funds opened new Teladoc Health positions in Q3 2021 and 117 closed out, a net change of -58 holders.
- The largest Teladoc Health buyer in Q3 2021 was Nikko Asset Management Americas, an estimated $250M added.
- The largest Teladoc Health seller in Q3 2021 was General Catalyst Group Management, an estimated $391M sold.
Based on aggregated 13F filings for Q3 2021.